CVS Health (CVS) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY22 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.99 +0.29%
Financial Fact:
Loss from discontinued operations, net of tax: -1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Loss from discontinued operations, net of tax: -1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $2.09, $0.09 better than the analyst estimate of $2.00. Revenue for the quarter came in at $81.16 billion versus the consensus estimate of $76.76 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.55-$8.65, versus the consensus of $8.55.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
